Glenmark receives ANDA approval for generic Protopic Ointment

18 Apr 2018 Evaluate

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Tacrolimus Ointment, 0.1%, the generic version of Protopic Ointment, 0.1%, of Leo Pharma AS.

According to IQVIA sales data for the 12 month period ending February 2018, the Protopic Ointment, 0.1% market2 achieved annual sales of approximately $109.0 million.

Glenmark’s current portfolio consists of 132 products authorized for distribution in the US marketplace and 61 ANDA’s pending approval with the USFDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

Glenmark Pharma Share Price

1938.35 19.30 (1.01%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×